Repare Therapeutics Cuts 25% of Workforce, Preclinical Team Most Affected

Repare Therapeutics is reducing its workforce by about 25%.
The preclinical team is the most affected by the layoffs.
This move is part of the company's R&D prioritization efforts.
The layoffs are indicative of a broader trend in the biotech industry, where several companies have announced significant job cuts in 2024.
Other biotech and pharmaceutical companies, such as BioMarin, Genentech, Novartis, and Sanofi, have also implemented layoffs and restructuring measures.
The layoffs in the biotech sector are part of a larger trend of job cuts across R&D-heavy industries, including tech and healthcare.